Damian Green
Company: Fred Hutchinson Cancer Research Center (FHCRC)
Job title: Associate Professor - Clinical Research Division
Seminars:
Chair’s Closing Remarks & End of Summit 3:00 pm
day: Day Two
Closing Panel Discussion: Future Directions for BCMA-Directed Therapies 3:00 pm
Pricing/Cost Accessibility changes Is improved trial design needed? How will they be commercialized? What is the ultimate limit of BCMA as a target for myeloma? How will cell therapy infrastructure evolve & how will this effect current situation? Potential limitations to BCMA and how other targets (FcRb5/FcR115, NC28, CS1, SIRH5) could fit in the future…Read more
Chair’s Opening Remarks 8:50 am
day: Day Two
Leveraging the Findings From First in-Human GSI-plus-BCMA Clinical Trial to Understand Mechanisms of Resistance & Optimize Efficacy 12:00 pm
Exploring why mechanisms of resistance to BCMA targeted therapies require further elucidation Understanding the impact of BCMA antigen density on response, needing to be further characterized Discussing why the approach to sequencing BCMA targeting agents may require careful considerationRead more
day: Day One
Chair’s Opening Remarks 8:50 am
day: Day One